Calendar

Week of Apr 13, 2026

Apr 16, 2026drug shortage118d agoMethylprednisolone Acetate Injection shortage — Par Health, USA LLCPFIZER INC

Status: Current. Reason: not specified. Form: Injection

Apr 16, 2026drug shortage118d agoMethylphenidate Hydrochloride Tablet, Extended Release shortage — Teva Pharmaceuticals USA, Inc.Teva Pharmaceuticals USA Inc

Status: Current. Reason: not specified. Form: Tablet

full page →fda drug shortages ↗

Apr 16, 2026drug shortage118d agoHydromorphone Hydrochloride Injection shortage — Teva Pharmaceuticals USA, Inc.Teva Pharmaceuticals USA Inc

Status: Current. Reason: not specified. Form: Injection

full page →fda drug shortages ↗

Apr 16, 2026drug shortage118d agoRopivacaine Hydrochloride Injection shortage — Caplin Steriles, Ltd.Caplin Steriles Ltd

Status: Current. Reason: not specified. Form: Injection

full page →fda drug shortages ↗

Apr 16, 2026drug shortage118d agoCromolyn Sodium Concentrate shortage — Micro Labs LTDMicro Labs Ltd

Status: Current. Reason: not specified. Form: Concentrate

full page →fda drug shortages ↗

Apr 16, 2026drug shortage118d agoIsocarboxazid Tablet shortage — Lifsa Drugs LLCHoffmann-La Roche Inc

Status: Current. Reason: not specified. Form: Tablet

full page →fda drug shortages ↗

Apr 16, 2026drug shortage118d agoAzacitidine Injection shortage — Teva Pharmaceuticals USA, Inc.Teva Pharmaceuticals USA Inc

Status: Current. Reason: not specified. Form: Injection

full page →fda drug shortages ↗

Apr 16, 2026drug shortage118d agoAzacitidine Injection shortage — Bristol Myers Squibb Co.BRISTOL MYERS SQUIBB CO

Status: Current. Reason: not specified. Form: Injection

full page →fda drug shortages ↗

Apr 16, 2026grant118d agoJOHNS HOPKINS UNIVERSITY — Blood-Brain Barrier Integrity and Immune Dynamics in Neuropsychiatric Sequela...Johns Hopkins University

NS grant. $633,378. PI: Alba Miranda Azola

full page →nih reporter ↗

Apr 16, 2026grant118d agoUNIVERSITY OF WASHINGTON — Development of molecular tools and mouse models to study neglected Sindbis vi...University of Washington

AI grant. $88,250. PI: Jennifer Lynn Hyde

full page →nih reporter ↗

Apr 16, 2026grant118d agoUNIVERSITY OF MARYLAND BALTIMORE — Epigenetic regulation of neo-sex chromosomes in filarial parasites

AI grant. $440,211. PI: Julie Dunning Hotopp

full page →nih reporter ↗

Apr 16, 2026grant118d agoUNIVERSITY OF TEXAS ARLINGTON — CONNECT: Cohort-Oriented Network kNowledgebase for Enhanced CollaboraTion

ES grant. $605,091. PI: Yike Shen

full page →nih reporter ↗

Apr 16, 2026grant118d agoGEORGETOWN UNIVERSITY — Epigenetic Biomarkers in Glioblastoma

NS grant. $429,000. PI: NAGI G AYAD

full page →nih reporter ↗

Apr 16, 2026grant118d agoEMORY UNIVERSITY — Understanding Multidrug-Resistant Pathogen Infections and their Treatment wit...Emory University

AI grant. $161,244. PI: TERESA GIL GIL

full page →nih reporter ↗

Apr 16, 2026grant118d agoUNIVERSITY OF PENNSYLVANIA — Metabolic Imaging Using Hyperpolarized Agents at Tracer ConcentrationsUniversity of Pennsylvania

CA grant. $415,623. PI: STEPHEN J KADLECEK

full page →nih reporter ↗

Apr 16, 2026grant118d agoBOSTON CHILDREN'S HOSPITAL — Molecular Mechanisms of Aire in Transcriptional RegulationBoston Children's Hospital

AI grant. $267,000. PI: Qianxia Zhang

full page →nih reporter ↗

Apr 16, 2026grant118d agoUNIVERSITY OF PITTSBURGH AT PITTSBURGH — The molecular and physiologic effects of calcineurin inhibitors on WNK body b...

DK grant. $769,882. PI: Cary Ragan Boyd-Shiwarski

full page →nih reporter ↗

Apr 16, 2026grant118d agoUNIV OF MASSACHUSETTS MED SCH WORCESTER — Examining the Effectiveness of School-based Health Centers (SBHCs) to Improve...

NR grant. $3,480,544. PI: Michelle Trivedi

full page →nih reporter ↗

Apr 16, 2026grant118d agoUNIVERSITY OF MICHIGAN AT ANN ARBOR — Volatile Organic Compound Impacts on Immune Functions During Pregnancy: Molec...

ES grant. $795,869. PI: Sean M Harris

full page →nih reporter ↗

Apr 16, 2026grant118d agoLOUISIANA STATE UNIV HSC SHREVEPORT — The role of ZBP1 in controlling HSV-1 pathogenesis

AI grant. $660,723. PI: Hongyan Guo

full page →nih reporter ↗

Apr 16, 2026grant118d agoICAHN SCHOOL OF MEDICINE AT MOUNT SINAI — Determinants of viral assembly and infectivity within the Ebola virus VP24 pr...

AI grant. $843,182. PI: Christopher F Basler

full page →nih reporter ↗

Apr 16, 2026grant118d agoUNIVERSITY OF CALIFORNIA, SAN DIEGO — The effects and mechanisms supporting psilocybin induced pain reliefUniversity of California San Diego

AT grant. $788,967. PI: ADAM L. Halberstadt

full page →nih reporter ↗

04/17/2026recall117d agoBreeder’s Edge, Shelter’s Choice recall: Animal & Veterinary, Food & Beverages

Canine milk replacer

full page →fda recalls ↗

Apr 17, 2026approval117d agoSODIUM ACETATE — FDA approvalSODIUM ACETATE

Sponsor: EXTROVIS. Form: SOLUTION. Route: INTRAVENOUS

full page →SODIUM ACETATE →fda approvals ↗

Apr 17, 2026approval117d agoCOSENTYX (SECUKINUMAB) — FDA approvalNOVARTIS AG

Sponsor: NOVARTIS PHARMS CORP. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Apr 17, 2026approval117d agoCOSENTYX (SECUKINUMAB) — FDA approvalNOVARTIS AG

Sponsor: NOVARTIS PHARMS CORP. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Apr 17, 2026approval117d agoCOSENTYX (SECUKINUMAB) — FDA approvalNOVARTIS AG

Sponsor: NOVARTIS PHARMS CORP. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Apr 17, 2026approval117d agoCOSENTYX (SECUKINUMAB) — FDA approvalNOVARTIS AG

Sponsor: NOVARTIS PHARMS CORP. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Apr 17, 2026approval117d agoVALPROIC ACID — FDA approvalVALPROIC ACID

Sponsor: QUAGEN. Form: SYRUP. Route: ORAL

full page →VALPROIC ACID →fda approvals ↗

Apr 17, 2026approval117d agoCARBAMAZEPINE — FDA approvalcarbamazepine ER

Sponsor: YICHANG HUMANWELL. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →carbamazepine ER →fda approvals ↗

Apr 17, 2026approval117d agoCALCIPOTRIENE — FDA approvalPrasco LLC

Sponsor: GLENMARK SPECLT. Form: CREAM. Route: TOPICAL

full page →fda approvals ↗

Apr 17, 2026approval117d agoESOMEPRAZOLE MAGNESIUM — FDA approvalesomeprazole magnesium DR

Sponsor: MARKSANS PHARMA. Form: CAPSULE, DELAYED RELEASE. Route: ORAL

full page →esomeprazole magnesium DR →fda approvals ↗

Apr 17, 2026approval117d agoLAMOTRIGINE — FDA approvalLAMOTRIGINE

Sponsor: GLENMARK PHARMS LTD. Form: TABLET, FOR SUSPENSION. Route: ORAL

full page →LAMOTRIGINE →fda approvals ↗

Apr 17, 2026approval117d agoLAMOTRIGINE — FDA approvalLAMOTRIGINE

Sponsor: GLENMARK PHARMS LTD. Form: TABLET, FOR SUSPENSION. Route: ORAL

full page →LAMOTRIGINE →fda approvals ↗

Apr 17, 2026approval117d agoTETRACYCLINE HYDROCHLORIDE — FDA approvalAmneal Pharmaceuticals of New York LLC

Sponsor: IMPAX LABS. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Apr 17, 2026approval117d agoTETRACYCLINE HYDROCHLORIDE — FDA approvalAmneal Pharmaceuticals of New York LLC

Sponsor: IMPAX LABS. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Apr 17, 2026drug shortage117d agoLisdexamfetamine Dimesylate Capsule shortage — AlvogenAlvogen Inc

Status: Current. Reason: not specified. Form: Capsule

full page →fda drug shortages ↗

Apr 17, 2026drug shortage117d agoLisdexamfetamine Dimesylate Capsule shortage — Mylan Pharmaceuticals Inc., a Viatris CompanyMylan Pharmaceuticals Inc

Status: Current. Reason: not specified. Form: Capsule

full page →fda drug shortages ↗

Apr 17, 2026drug shortage117d agoAmphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet shortage — AlvogenAlvogen Inc

Status: Current. Reason: not specified. Form: Tablet

full page →fda drug shortages ↗

Apr 17, 2026drug shortage117d agoDextrose Monohydrate 5% Injection shortage — Otsuka ICU Medical LLC

Status: Current. Reason: not specified. Form: Injection

full page →fda drug shortages ↗

Apr 17, 2026drug shortage117d agoLisdexamfetamine Dimesylate Tablet, Chewable shortage — Sun Pharmaceutical Industries, Inc.Sun Pharmaceutical Industries Ltd

Status: Current. Reason: not specified. Form: Tablet, Chewable

full page →fda drug shortages ↗

Apr 17, 2026drug shortage117d agoMethylphenidate Hydrochloride Tablet, Extended Release shortage — Trigen Laboratories, LLCTrigen Laboratories Inc

Status: Current. Reason: not specified. Form: Tablet

full page →fda drug shortages ↗

Apr 17, 2026drug shortage117d agoAmino Acid Injection shortage — Otsuka ICU Medical LLC

Status: Current. Reason: not specified. Form: Injection

full page →fda drug shortages ↗

Apr 17, 2026drug shortage117d agoSterile Water Irrigant shortage — Otsuka ICU Medical LLC

Status: Current. Reason: not specified. Form: Irrigant

full page →fda drug shortages ↗

Apr 17, 2026drug shortage117d agoEtomidate Injection shortage — Mylan Institutional, a Viatris CompanyMylan Institutional Inc

Status: Current. Reason: not specified. Form: Injection

full page →fda drug shortages ↗

Apr 17, 2026drug shortage117d agoDextrose Monohydrate 10% Injection shortage — Otsuka ICU Medical LLC

Status: Current. Reason: not specified. Form: Injection

full page →fda drug shortages ↗

Apr 17, 2026drug shortage117d agoLisdexamfetamine Dimesylate Capsule shortage — Sun Pharmaceutical Industries, Inc.Sun Pharmaceutical Industries Ltd

Status: Current. Reason: not specified. Form: Capsule

full page →fda drug shortages ↗

Apr 17, 2026drug shortage117d agoTechnetium TC-99M Pyrophosphate Kit Injection shortage — Sun Pharmaceutical Industries, Inc.Sun Pharmaceutical Industries Ltd

Status: Current. Reason: not specified. Form: Injection

full page →fda drug shortages ↗

Apr 17, 2026drug shortage117d agoPenicillin G Benzathine Injection shortage — Pfizer Inc.PFIZER INC

Status: Current. Reason: not specified. Form: Injection

full page →fda drug shortages ↗

Apr 17, 2026drug shortage117d agoMethylphenidate Hydrochloride Tablet, Extended Release shortage — Janssen PharmaceuticalsJanssen Therapeutics

Status: Current. Reason: not specified. Form: Tablet

full page →fda drug shortages ↗

← prev

page 7 of 83

Week of Apr 13, 2026